This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event November 9-17, 2021
In-Person November 9-10 • Virtual November 16-17DoubleTree by Hilton Center City • Philadelphia, PA

Delivered as a Hybrid Event November 9-17, 2021
In-Person November 9-10 • Virtual November 16-17,
DoubleTree by Hilton Center City • Philadelphia, PA

Stay on the Pulse of Federal and State Reporting Requirements, Policy Initiatives & Strategic Best Practices for Compliance

Discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Assess how companies are planning internally for these changes, hear updates post-election impacting drug pricing transparency and gain a preview of what’s to come in 2022.

Educational Training to Ensure Compliance and Transparency Across the Life Sciences

Stay on the Pulse of Federal and State Reporting Requirements

  • Attend the Federal Spotlight Session Examining Federal Initiatives for Pricing Transparency
  • Discover Session Insights into New State Transparency Laws
  • Strengthen Understanding of New Legislation through Attending the BIO and PhRMA Address

Navigate Complexities of Key Policy Initiatives

  • Discover Trends in Enforcement Action in the Enforcement Spotlight Session
  • Evaluate the Role of New Product Launches on Drug Pricing Transparency Implications
  • Engage in Conversation on the State of the Industry and the Drug Pricing Transparency Landscape

Identify and Gain Strategies for Best Practices for Compliance

  • Evaluate Internal Planning Processes for Future Drug Pricing Transparency Regulations
  • Discover Strategies to Ensure Operational Readiness
  • Discuss Top Industry Challenges in the Ask the Experts Panel Discussion
  • Analyze Benchmarking Results Collected from Conference Attendees

Who Should Attend

You will benefit from attending this event if you are in the pharmaceutical, medical device, or biotechnology industries with responsibilities or involvement in the following areas:

  • Pricing
  • Compliance
  • Strategy Analyst
  • Reimbursement
  • Contracting
  • State/Transparency Reporting
  • Legal / Counsel
  • Market Access
  • Government Affairs
  • Government Pricing/Programs/Compliance
  • Commercial Operations
  • National/Strategic/Corporate Accounts
  • Managed Care/Markets
  • Corporate Communications

This conference will also benefit consultants, technology vendors and companies providing services to the above audience.

Informa AllSecure is Informa’s approach to enhanced health and safety standards at our events following COVID-19

Connect and Network with Key Decision-Makers at Drug Pricing Transparency

Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

For more information about custom opportunities to reach a qualified audience, please contact us here.

VP & Assistant General Counsel

Pfizer Inc

Informa Connect’s Drug Pricing conference helps you keep up to the date on the latest developments in drug pricing.